A Registry Study on HIV-related Lymphoma

Recruiting now

Conditions studied: AIDS Related Lymphoma, HIV Related Lymphoma

In brief

Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.

Key facts

Study ID

NCT05231135

Run by

Rotkreuzklinikum München gGmbH

People needed

300

Starts

2021-08-25

Expected to finish

2029-08-31

Last updated by the study team

2023-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma
• HIV-infection at time of lymphoma diagnosis
• Lymphoma diagnosis since 01.01.2010
• Adult patients ≥ 18 years
• Written informed consent

You may not qualify if…

• HIV-diagnosis > 3 months after the diagnosis of malignant lymphoma
• Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)

Where it is running

• Red Cross Hospital Munich — Munich, Select One Option, Germany (enrolling)
• University Hospital Cologne — Cologne, Germany (enrolling)
• Hospital de la Santa Creu i Sant Pau — Barcelona, Spain (enrolling)
• Hospital Universitario de Salamanca — Salamanca, Spain (enrolling)
• Amsterdam University Medical Centers — Amsterdam, Netherlands
• University Hospital of Wales — Cardiff, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.